New peer-reviewed, scientific study shows Vyleesi enhances sexual brain processing in premenopausal women with HSDD. Click here to learn more ›

Palatin Technologies, Inc. to Report Fiscal Year 2011 First Quarter Results; Teleconference and Webcast to be Held on November 16, 2010

CRANBURY, N.J., Nov. 12, 2010 /PRNewswire-FirstCall/ — Palatin Technologies, Inc. (NYSE Amex: PTN) will announce its first quarter, fiscal year 2011 financial results on Tuesday, November 16, 2010 before the open of the U.S. financial markets.

Palatin will also conduct a conference call and live audio webcast hosted by its executive management team on November 16, 2010, which will include discussion of the results of operations in greater detail and an update on corporate developments.

Schedule for the Financial Results Press Release, Conference Call / Webcast

– Q1 Fiscal Year 2011 Financial Results Press Release

11/16/2010 at 7:30 a.m. ET



– Q1 Fiscal Year 2011 Conference Call-Live

11/16/2010 at 11:00 a.m. ET

Domestic Dial-In Number

1-888-215-7015

International Dial-In Number

1-913-312-0376

Pass code

5104164



– Q1 Fiscal Year 2011 Conference Call-Replay

11/16-11/23/2010

Domestic Dial-In Number

1-888-203-1112

International Dial-In Number

1-719-457-0820

Pass code

5104164



– Webcast Live and Replay Access

http://www.palatin.com



The webcast and replay can be accessed by logging on to the “Investor/Media Center-Webcasts” section of Palatin’s website at http://www.palatin.com

About Palatin Technologies, Inc.

Palatin Technologies, Inc. is a biopharmaceutical company dedicated to the development of peptide, peptide mimetic and small molecule agonists with a focus on melanocortin and natriuretic peptide receptor systems. Palatin’s strategy is to develop products and then form marketing collaborations with industry leaders in order to maximize their commercial potential.  For additional information regarding Palatin, please visit Palatin Technologies’ website at www.palatin.com.

SOURCE Palatin Technologies, Inc.

Scroll to Top